Literature DB >> 9618944

Development and characterization of new immortalized human breast cell lines

.   

Abstract

New human breast cell lines were developed from metastatic breast cancer tissues and normal breast tissues. Primary cultures were initiated from cellular outgrowths of explanted tissues or from mechanically isolated cells in two serum-free media. Cell cultures derived from both cancer and normal tissues were immortalized with pRSV-T plasmid to generate permanent breast cell lines that exhibited an epithelial morphology. Cell lines generated in this study were characterized with respect to morphology, growth rate, karyotype, presence of specific genes, and the expression of epithelial and breast markers. The cell lines expressed the epithelial cell markers, cytokeratins 8 and 18, and retained the capacity to produce human milk fat globulin. They also express the BRCA-1, erbB2, and EGF receptor genes and possess the H-ras, K-ras, and p53 genes. Preliminary data showed that one of the new cancer cell lines was highly sensitive to the cytotoxic action of taxol. It is envisioned that the new breast cell lines will be useful as targets for identification of therapeutic agents against breast cancer and as models for carcinogenesis studies.

Entities:  

Year:  1998        PMID: 9618944      PMCID: PMC3449551          DOI: 10.1023/a:1007953429252

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  34 in total

1.  THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS.

Authors:  L HAYFLICK
Journal:  Exp Cell Res       Date:  1965-03       Impact factor: 3.905

2.  Breast tumor cell lines from pleural effusions.

Authors:  R Cailleau; R Young; M Olivé; W J Reeves
Journal:  J Natl Cancer Inst       Date:  1974-09       Impact factor: 13.506

3.  Differential tumorigenicity of two autologous human breast carcinoma cell lines, HMT-3909S1 and HMT-3909S8, established in serum-free medium.

Authors:  O W Petersen; B van Deurs; K V Nielsen; M W Madsen; I Laursen; I Balslev; P Briand
Journal:  Cancer Res       Date:  1990-02-15       Impact factor: 12.701

4.  New colorimetric cytotoxicity assay for anticancer-drug screening.

Authors:  P Skehan; R Storeng; D Scudiero; A Monks; J McMahon; D Vistica; J T Warren; H Bokesch; S Kenney; M R Boyd
Journal:  J Natl Cancer Inst       Date:  1990-07-04       Impact factor: 13.506

5.  Growth of diploid cells from breast cancers.

Authors:  S R Wolman; H S Smith; M Stampfer; A J Hackett
Journal:  Cancer Genet Cytogenet       Date:  1985-03-01

6.  Establishment of immortalized alveolar type II epithelial cell lines from adult rats.

Authors:  K E Driscoll; J M Carter; P T Iype; H L Kumari; L L Crosby; M J Aardema; R J Isfort; D Cody; M H Chestnut; J L Burns
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995 Jul-Aug       Impact factor: 2.416

7.  Serum-free growth of human mammary epithelial cells: rapid clonal growth in defined medium and extended serial passage with pituitary extract.

Authors:  S L Hammond; R G Ham; M R Stampfer
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

Review 8.  The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: a review on 5232 patients.

Authors:  J G Klijn; P M Berns; P I Schmitz; J A Foekens
Journal:  Endocr Rev       Date:  1992-02       Impact factor: 19.871

Review 9.  Tumor suppressor p53 mutations and breast cancer: a critical analysis.

Authors:  M A Ozbun; J S Butel
Journal:  Adv Cancer Res       Date:  1995       Impact factor: 6.242

10.  Control of growth and squamous differentiation in normal human bronchial epithelial cells by chemical and biological modifiers and transferred genes.

Authors:  A M Pfeifer; J F Lechner; T Masui; R R Reddel; G E Mark; C C Harris
Journal:  Environ Health Perspect       Date:  1989-03       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.